search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
137 new news items in the last 24 hours
  1. Home
  2. Educație

India has authorized the use of the Qdenga vaccine against dengue fever

Gabriel Dumitrache
whatsapp
facebook
linkedin
x
copy-link copy-link
21 July 2026, 16:37
main event image
Health
Foto: Shutterstock
google-preference

Always see our news on Google

The Indian Ministry of Health has announced the approval of the Qdenga vaccine, manufactured by Takeda, for use in the domestic market. According to the World Health Organization, dengue fever affects half of the global population, with 100-400 million infections annually.


In India, over 1 million cases of dengue fever have been reported since 2021, including 1,500 deaths. The virus, transmitted by mosquitoes, causes severe symptoms, including fever, muscle pain, and, in rare cases, death. The authorized vaccine is recommended in two doses for individuals aged between 4 and 60 years and has already been approved by health agencies in about 40 countries.


Additionally, the Indian group Panacea Biotec has begun the final phase of clinical trials for a single-dose vaccine. Recently, Brazil suspended the use of another single-dose vaccine due to suspected deaths.

Sources

sursa imagine
G4Media
India a autorizat în premieră utilizarea unui vaccin împotriva febrei denga
sursa imagine
Agerpres
India a autorizat în premieră utilizarea unui vaccin împotriva febrei denga
sursa imagine
Stiripesurse
India a autorizat în premieră utilizarea unui vaccin împotriva febrei denga, boală care amenință jumătate din populația lumii

Latest News

20:34

Czechia is blocking Russian athletes from participating in the U18 Ice Hockey World Championship, despite a CAS ruling

20:28

Three Romanians are on trial in Germany for violent robberies, including one targeting Michael Schumacher’s former manager

20:24

A Romanian man was arrested in Austria after a confrontation in which he allegedly fired a blank-firing pistol

20:18

ECHR bars a Romanian lawyer for two years / He used AI, which fabricated cases and paragraphs of case law

20:13

The Government explains the expansion of Deputy Prime Minister Marian Neacșu’s powers

See more news

NEWS ON THE SAME TOPICS

event image
Health
The pharmaceutical group Minapharm will develop a candidate vaccine against the Bundibugyo Ebola strain, with funding of 16.5 million dollars.
event image
International
Bangladesh records the world's worst measles outbreak, with 999 suspected and confirmed deaths since March
event image
International
France confirms the first human case of Shamonda virus
event image
Current Affairs
The Ministry of Health announces that 370,000 doses of influenza vaccine are available in warehouses in Romania and can be ordered by pharmacies
event image
International
Nigeria confirms the first case of Ebola in more than a decade. 44 people are being monitored after a patient in Abuja became infected
event image
Health
Moderna and Merck announce promising results for the personalized vaccine against melanoma recurrence
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
India Dengue fever denga

Editor’s Recommendations

main event image
INSCOP Surveys
11 hours ago

November 2026: Informat.ro – INSCOP Research BAROMETER, 15th Edition – Chapter IX: Freedom vs. Security

main event image
Exclusive
9 hours ago

Exclusive Monitor of Ministers by NewsVibe: November 12–18, 2026 / Rogobete, Nazare and Neacșu top online visibility amid the Lyrica controversy and state-owned company reform

main event image
Current Affairs
3 hours ago

The Ilfov Tribunal decided to place Călin Georgescu and Ionel Rusen under house arrest. The decision is not final.

Sources
imagine sursa
imagine sursa
imagine sursa
main event image
Exclusive
3 hours ago

DOC Anthropic debuts Thursday on Nasdaq: the biggest test of the market’s enthusiasm for artificial intelligence

main event image
Current Affairs
8 hours ago

SUMMARY Earthquake alerts: why Japan warns the population before the arrival of strong seismic waves, while Romania does not use RO-Alert

main event image
Exclusive
4 hours ago

EXCLUSIVE Ranking of countries in relevant Romanian online sources: Ukraine leads the foreign agenda. Security and the economy define the week

main event image
Opinions
7 hours ago

Raed Arafat, a Mr. Bean at DSU

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol